Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  O'Neal, Wanda K ^a   Anderson, Wayne ^b   Basta, Patricia V ^b   Carretta, Elizabeth E ^c   Doerschuk, Claire M ^a   Barr, R G ^d   Bleecker, Eugene R ^e   Christenson, Stephanie A ^f   Curtis, Jeffrey L ^g,h   Han, Meilan K ^g   Hansel, Nadia N ⁱ   Kanner, Richard E ^j   Kleerup, Eric C ^k   Martinez, Fernando J ^g   Miller, Bruce E ^l   Peters, Stephen P ^e   Rennard, Stephen I ^m   Scholand, Mary B ^j   Tal Singer, Ruth ^l   Woodruff, Prescott G ^f   Couper, David J ^c   Davis, Sonia M ^c   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d University of California at San Francisco ^*  (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h 3495 Bailey Ave Buffalo N   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l GLAXOSMITHKLINE   (United States)

^m UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

more..

Author keywords

Biomarkers; Blood analytes; Chronic obstructive pulmonary disease; COPD; EDTA plasma; Multiplex assays; P100 plasma; Pilot study; Serum; SPIROMICS

Indexed keywords

BIOLOGICAL MARKERS; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; EDETIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA; PROTEASE INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SERUM;

EID: 84892173588     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-9     Document Type: Article

References (25)

1. Couper D, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S, for the SPIROMICS Research Group Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 2013, 10.1136/thoraxjnl-2013-203897. Epub ahead of print, for the SPIROMICS Research Group.
2. Biancotto A, Feng X, Langweiler M, Young NS, McCoy JP. Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine 2012, 60:438-446. 10.1016/j.cyto.2012.05.019, 3449030, 22705152.
3. Yu Z, Kastenmuller G, He Y, Belcredi P, Moller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-Sattler R. Differences between human plasma and serum metabolite profiles. PLoS ONE 2011, 6:e21230. 10.1371/journal.pone.0021230, 3132215, 21760889.
4. Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, Schulz-Knappe P, Speicher DW, Vitzthum F, Haab BB, Siest G, Chan DW. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5:3262-3277. 10.1002/pmic.200401245, 16052621.
5. Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, Selby PJ. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 2005, 51:1637-1649. 10.1373/clinchem.2005.051417, 16002455.
6. Golanski J, Pietrucha T, Baj Z, Greger J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 1996, 83:199-216. 10.1016/0049-3848(96)00129-6, 8840462.
7. De JW, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009, 10:52. 10.1186/1471-2172-10-52, 2761376, 19785746.
8. Mannello F. Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thromb Vasc Biol 2008, 28:611-614. 10.1161/ATVBAHA.107.159608, 18354094.
9. Fu Q, Zhu J, Van Eyk JE. Comparison of multiplex immunoassay platforms. Clin Chem 2010, 56:314-318. 10.1373/clinchem.2009.135087, 2905867, 20022982.
10. Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, Keller S, Weinryb I, Green M, Duan L, Rogers JA, Millham R, O'Brien PJ, Sailstad J, Khan M, Ray C, Wagner JA. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 2006, 23:312-328. 10.1007/s11095-005-9045-3, 16397743.
11. Ricos C, Cava F, Garcia-Lario JV, Hernandez A, Iglesias N, Jimenez CV, Minchinela J, Perich C, Simon M, Domenech MV, Alvarez V. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004, 64:175-184. 10.1080/00365510410004885, 15222627.
12. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005, 3:1894-1904. 10.1111/j.1538-7836.2005.01365.x, 16102057.
13. Thrailkill K, Cockrell G, Simpson P, Moreau C, Fowlkes J, Bunn RC. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens. Clin Chem Lab Med 2006, 44:503-504. 2242291, 16599849.
14. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999, 6:89-95. 95666, 9874670.
15. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988, 70:327-333. 10.1111/j.1365-2141.1988.tb02490.x, 3264718.
16. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001, 47:617-623.
17. Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, Zelmanovic D, Newland A. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem 2002, 48:891-899.
18. Aguilar-Mahecha A, Kuzyk MA, Domanski D, Borchers CH, Basik M. The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines. PLoS ONE 2012, 7:e38290. 10.1371/journal.pone.0038290, 3368926, 22701622.
19. Randall SA, McKay MJ, Baker MS, Molloy MP. Evaluation of blood collection tubes using selected reaction monitoring MS: implications for proteomic biomarker studies. Proteomics 2010, 10:2050-2056. 10.1002/pmic.200900517, 20209509.
20. Wildes D, Wells JA. Sampling the N-terminal proteome of human blood. Proc Natl Acad Sci USA 2010, 107:4561-4566. 10.1073/pnas.0914495107, 2842036, 20173099.
21. Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Mohring T, Schulz-Knappe P. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5:3414-3422. 10.1002/pmic.200401219, 16038021.
22. Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res 2007, 6:1768-1781. 10.1021/pr060550h, 17411080.
23. Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013, 309:2353-2361. 10.1001/jama.2013.5732, 23757083.
24. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, MacNee W, Rennard S, Silverman E, Vestbo J, Wouters E, Agusti A. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 185:1065-1072. 10.1164/rccm.201110-1792OC, 22427534.
25. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Pare PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181:1329-1335. 10.1164/rccm.200812-1902OC, 2894408, 20075389.